Macrophage migration inhibitory factor regulates AKT signaling in hypoxic culture to modulate senescence of human mesenchymal stem cells

Stem Cells and Development

Volumn 23, Issue 8, 2014, Pages 852-865

  Palumbo, SunMi ^a   Tsai, Tsung Lin ^a,b   Li, Wan Ju ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CELL SURFACE MARKER; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; PROTEIN KINASE B; ISOMERASE; MIF PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIC CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; NANOG GENE; NUCLEOTIDE SEQUENCE; OCT3 GENE; OCT4 GENE; P16 GENE; P21 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; SIGNAL TRANSDUCTION; SOX2 GENE; STAINING; UPREGULATION; CELL AGING; CELL CULTURE; CELL HYPOXIA; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

ADULT; AGED; CELL AGING; CELL DIFFERENTIATION; CELL HYPOXIA; CELLS, CULTURED; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MESENCHYMAL STROMAL CELLS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84898754463     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0294     Document Type: Article

References (72)

1. Kuilman T, C Michaloglou, WJ Mooi and DS Peeper. (2010). The essence of senescence. Genes Dev 24:2463-2479.
2. Bonab MM, K Alimoghaddam, F Talebian, SH Ghaffari, A Ghavamzadeh and B Nikbin. (2006). Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7:14.
3. Geissler S, M Textor, J Kuhnisch, D Konnig, O Klein, A Ode, T Pfitzner, J Adjaye, G Kasper and GN Duda. (2012). Functional comparison of chronological and in vitro aging: differential role of the cytoskeleton and mitochondria in mesenchymal stromal cells. PLoS One 7:e52700.
4. Baxter MA, RF Wynn, SN Jowitt, JE Wraith, LJ Fairbairn and I Bellantuono. (2004). Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22:675-682.
5. Kim KS, MS Kim, YB Seu, HY Chung, JH Kim and JR Kim. (2007). Regulation of replicative senescence by insulin-like growth factor-binding protein 3 in human umbilical vein endothelial cells. Aging Cell 6:535-545.
6. Wajapeyee N, RW Serra, X Zhu, M Mahalingam and MR Green. (2010). Role for IGFBP7 in senescence induction by BRAF. Cell 141:746-747.
7. Kuilman T, C Michaloglou, LC Vredeveld, S Douma, R van Doorn, CJ Desmet, LA Aarden, WJ Mooi and DS Peeper. (2008). Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133: 1019-1031.
8. Castro P, C Xia, L Gomez, DJ Lamb and M Ittmann. (2004). Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia. Prostate 60:153-159.
9. Senturk S, M Mumcuoglu, O Gursoy-Yuzugullu, B Cingoz, KC Akcali and M Ozturk. (2010). Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth. Hepatology 52:966-974.
10. Brummelkamp TR, RM Kortlever, M Lingbeek, F Trettel, ME MacDonald, M van Lohuizen and R Bernards. (2002). TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence. J Biol Chem 277:6567-6572.
11. Ota H, M Eto, MR Kano, T Kahyo, M Setou, S Ogawa, K Iijima, M Akishita and Y Ouchi. (2010). Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler Thromb Vasc Biol 30:2205-2211.
12. Hasan MR, SH Ho, DA Owen and IT Tai. (2011). Inhibition of VEGF induces cellular senescence in colorectal cancer cells. Int J Cancer 129:2115-2123.
13. Jin Y, T Kato, M Furu, A Nasu, Y Kajita, H Mitsui, M Ueda, T Aoyama, T Nakayama, T Nakamura and J Toguchida. (2010). Mesenchymal stem cells cultured under hypoxia escape from senescence via down-regulation of p16 and extracellular signal regulated kinase. Biochem Biophys Res Commun 391:1471-1476.
14. Tsai CC, YJ Chen, TL Yew, LL Chen, JY Wang, CH Chiu and SC Hung. (2011). Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through downregulation of E2A-p21 by HIF-TWIST. Blood 117:459-469.
15. Leontieva OV, V Natarajan, ZN Demidenko, LG Burdelya, AV Gudkov and MV Blagosklonny. (2012). Hypoxia suppresses conversion from proliferative arrest to cellular senescence. Proc Natl Acad Sci U S A 109:13314-13318.
16. Mohyeldin A, T Garzon-Muvdi and A Quinones-Hinojosa. (2010). Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7:150-161.
17. Fehrer C, R Brunauer, G Laschober, H Unterluggauer, S Reitinger, F Kloss, C Gully, R Gassner and G Lepperdinger. (2007). Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6:745-757.
18. Kennedy AL, JP Morton, I Manoharan, DM Nelson, NB Jamieson, JS Pawlikowski, T McBryan, B Doyle, C McKay, et al. (2011). Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis. Mol Cell 42:36-49.
19. Liu S, S Liu, X Wang, J Zhou, Y Cao, F Wang and E Duan. (2011). The PI3K-Akt pathway inhibits senescence and promotes self-renewal of human skin-derived precursors in vitro. Aging Cell 10:661-674.
20. Watanabe S, H Umehara, K Murayama, M Okabe, T Kimura and T Nakano. (2006). Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 25:2697-2707.
21. Nogueira V, Y Park, CC Chen, PZ Xu, ML Chen, I Tonic, T Unterman and N Hay. (2008). Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14:458-470.
22. Oyama K, T Okawa, H Nakagawa, M Takaoka, CD Andl, SH Kim, A Klein-Szanto, JA Diehl, M Herlyn, W El-Deiry and AK Rustgi. (2007). AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture. Oncogene 26:2353-2364.
23. Minamino T, H Miyauchi, K Tateno, T Kunieda and I Komuro. (2004). Akt-induced cellular senescence: implication for human disease. Cell Cycle 3:449-451.
24. Beitner-Johnson D, RT Rust, TC Hsieh and DE Millhorn. (2001). Hypoxia activates Akt and induces phosphorylation of GSK-3 in PC12 cells. Cell Signal 13:23-27.
25. Lee SM, CT Lee, YW Kim, SK Han, YS Shim and CG Yoo. (2006). Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells. Cancer Lett 242:231-238.
26. Yamaguchi A, M Tamatani, H Matsuzaki, K Namikawa, H Kiyama, MP Vitek, N Mitsuda and M Tohyama. (2001). Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J Biol Chem 276:5256-5264.
27. Calandra T and T Roger. (2003). Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791-800.
28. Baugh JA, M Gantier, L Li, A Byrne, A Buckley and SC Donnelly. (2006). Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem Biophys Res Commun 347:895-903.
29. Bloom BR and B Bennett. (1966). Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80-82.
30. David JR. (1966). Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cellantigen interaction. Proc Natl Acad Sci USA 56:72-77.
31. Tampanaru-Sarmesiu A, L Stefaneanu, K Thapar, K Kovacs, T Donnelly, CN Metz and R Bucala. (1997). Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas. Arch Pathol Lab Med 121:404-410.
32. Rice EK, GH Tesch, Z Cao, ME Cooper, CN Metz, R Bucala, RC Atkins and DJ Nikolic-Paterson. (2003). Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II. Kidney Int 63:1265-1275.
33. Taranto E, JR Xue, EF Morand and M Leech. (2009). Modulation of expression and cellular distribution of p21 by macrophage migration inhibitory factor. J Inflamm (Lond) 6:24.
34. Bernhagen J, M Bacher, T Calandra, CN Metz, SB Doty, T Donnelly and R Bucala. (1996). An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 183: 277-282.
35. Bacher M, CN Metz, T Calandra, K Mayer, J Chesney, M Lohoff, D Gemsa, T Donnelly and R Bucala. (1996). An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93:7849-7854.
36. Mitchell RA, CN Metz, T Peng and R Bucala. (1999). Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 274:18100-18106.
37. Ren Y, HM Chan, Z Li, C Lin, J Nicholls, CF Chen, PY Lee, V Lui, M Bacher and PK Tam. (2004). Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene 23:4146-4154.
38. Fingerle-Rowson G, O Petrenko, CN Metz, TG Forsthuber, R Mitchell, R Huss, U Moll, W Muller and R Bucala. (2003). The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci USA 100:9354-9359.
39. Denz A, C Pilarsky, D Muth, F Ruckert, HD Saeger and R Grutzmann. (2010). Inhibition of MIF leads to cell cycle arrest and apoptosis in pancreatic cancer cells. J Surg Res 160:29-34.
40. Hudson JD, MA Shoaibi, R Maestro, A Carnero, GJ Hannon and DH Beach. (1999). A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190: 1375-1382.
41. Welford SM, B Bedogni, K Gradin, L Poellinger, M Broome Powell and AJ Giaccia. (2006). HIF1alpha delays premature senescence through the activation of MIF. Genes Dev 20:3366-3371.
42. Johnstone B, TM Hering, AI Caplan, VM Goldberg and JU Yoo. (1998). In vitro chondrogenesis of bone marrowderived mesenchymal progenitor cells. Exp Cell Res 238: 265-272.
43. Bell EL, TA Klimova, J Eisenbart, PT Schumacker and NS Chandel. (2007). Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia. Mol Cell Biol 27: 5737-5745.
44. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, Dj Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. Cytotherapy 8:315-317.
45. Atadja P, H Wong, I Garkavtsev, C Veillette and K Riabowol. (1995). Increased activity of p53 in senescing fibroblasts. Proc Natl Acad Sci USA 92:8348-8352.
46. Alcorta DA, Y Xiong, D Phelps, G Hannon, D Beach and JC Barrett. (1996). Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 93: 13742-13747.
47. Hara E, R Smith, D Parry, H Tahara, S Stone and G Peters. (1996). Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16:859-867.
48. Tsai CC, PF Su, YF Huang, TL Yew and SC Hung. (2012). Oct4 and Nanog directly regulate Dnmt1 to maintain selfrenewal and undifferentiated state in mesenchymal stem cells. Mol Cell 47:169-182.
49. Yu KR, SR Yang, JW Jung, H Kim, K Ko, DW Han, SB Park, SW Choi, SK Kang, H Scholer and KS Kang. (2012). Cd49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells 30:876-887.
50. Riekstina U, I Cakstina, V Parfejevs, M Hoogduijn, G Jankovskis, I Muiznieks, R Muceniece and J Ancans. (2009). Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev 5:378-386.
51. Lue H, M Thiele, J Franz, E Dahl, S Speckgens, L Leng, G Fingerle-Rowson, R Bucala, B Luscher and J Bernhagen. (2007). Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26:5046-5059.
52. Schwartz V, H Lue, S Kraemer, J Korbiel, R Krohn, K Ohl, R Bucala, C Weber and J Bernhagen. (2009). A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett 583:2749-2757.
53. Amin MA, OV Volpert, JM Woods, P Kumar, LA Harlow and AE Koch. (2003). Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 93:321-329.
54. Parrinello S, E Samper, A Krtolica, J Goldstein, S Melov and J Campisi. (2003). Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 5:741-747.
55. Yao Z, Y Okabayashi, Y Yutsudo, T Kitamura, W Ogawa and M Kasuga. (2002). Role of Akt in growth and survival of PANC-1 pancreatic cancer cells. Pancreas 24:42-46.
56. Kennedy AL, PD Adams and JP Morton. (2011). Ras, PI3K/Akt and senescence: paradoxes provide clues for pancreatic cancer therapy. Small GTPases 2:264-267.
57. Hirose Y, M Katayama, OK Mirzoeva, MS Berger and RO Pieper. (2005). Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence. Cancer Res 65:4861-4869.
58. Ohta S, A Misawa, R Fukaya, S Inoue, Y Kanemura, H Okano, Y Kawakami and M Toda. (2012). Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells. J Cell Sci 125:3210-3220.
59. Coppe JP, PY Desprez, A Krtolica and J Campisi. (2010). The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5:99-118.
60. Rodier F, JP Coppe, CK Patil, WA Hoeijmakers, DP Munoz, SR Raza, A Freund, E Campeau, AR Davalos and J Campisi. (2009). Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 11:973-979.
61. Kojima H, T Inoue, H Kunimoto and K Nakajima. (2013). IL-6-STAT3 signaling and premature senescence. JAKSTAT 2:4, e25763.
62. Hideshima T, N Nakamura, D Chauhan and KC Anderson. (2001). Biological sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene 20:5991-6000.
63. Hsu JH, Y Shi, L Hu, M Fisher, TF Franke and A Lichtenstein. (2002). Role of the AKT kinase in expansion of multiple myeloma clones: on cytokine-dependent proliferative and survival responses. Oncogene 21:1391-1400.
64. Calandra T, J Bernhagen, RA Mitchell and R Bucala. (1994). Macrophage is an important and previously unrecognized source of macrophage-migration inhibitory factor. J Exp Med 179:1895-1902.
65. Benigni F, T Atsumi, T Calandra, C Metz, B Echtenacher, T Peng and R Bucala. (2000). The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest 106:1291-1300.
66. Huh JR, M Guo and BA Hay. (2004). Compensatory proliferation induced by cell death in the Drosophila wing disc requires activity of the apical cell death caspase Dronc in a nonapoptotic role. Curr Biol 14:1262-1266.
67. Ryoo HD, T Gorenc and H Steller. (2004). Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell 7:491-501.
68. Takeuchi S, A Takahashi, N Motoi, S Yoshimoto, T Tajima, K Yamakoshi, A Hirao, S Yanagi, K Fukami, et al. (2010). Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo. Cancer Res 70:9381-9390.
69. Wilson JM, PL Coletta, RJ Cuthbert, N Scott, K MacLennan, G Hawcroft, L Leng, JB Lubetsky, KK Jin, et al. (2005). Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 129:1485-1503.
70. Meyer-Siegler KL, KA Iczkowski and PL Vera. (2005). Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer. BMC Cancer 5:73.
71. Bando H, G Matsumoto, M Bando, M Muta, T Ogawa, N Funata, J Nishihira, M Koike and M Toi. (2002). Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread. Jpn J Cancer Res 93:389-396.
72. Bucala R and SC Donnelly. (2007). Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26:281-285.